DS
IDIX

David Shaw’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

David Shaw’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-569,817
Closed -$13.7M – 4679
2014
Q2 		$13.7M Buy
569,817
+411,302
+259% +$4.29M 0.02% 890
2014
Q1 		$956K Sell
158,515
-479,794
-75% -$3.35M ﹤0.01% 3066
2013
Q4 		$3.82M Sell
638,309
-105,485
-14% -$488K 0.01% 1921
2013
Q3 		$3.88M Buy
743,794
+71,303
+11% +$312K 0.01% 1832
2013
Q2 		$2.43M Buy
+672,491
New +$2.75M ﹤0.01% 1941

David Shaw's IDIX Position: Q3 2014 in Review

David Shaw sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 569,817 shares — an estimated $13.7M sold.

David Shaw first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $13.7M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • David Shaw reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • David Shaw sold 569,817 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $13.7M.
  • David Shaw first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • David Shaw's IDENIX PHARMACEUTICALS INC position peaked at $13.7M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on D.E. Shaw & Co's 13F filing for Q3 2014, filed 14 Nov 2014.